No Data
Chongqing Taiji Industry (600129.SH): Huagai granules have obtained the registration certificate for Chinese Patent Medicine in Macau.
On January 3, Gronghui reported that Chongqing Taiji Industry (600129.SH) announced that on January 2, 2025, its wholly-owned subsidiary, Taiji Group Macau Pharmaceutical Research Institute Co., Ltd. (referred to as: Macau Company), received the "Chinese Patent Medicine Registration Certificate" from the Macau Pharmaceutical Supervisory Authority for Huagai Granules【Taiji】(specification: 4.13g per bag). The prescription for this product comes from the Song Dynasty's "Tai Ping Hui Min He Ji Ju Fang" and is listed in the "Catalogue of Ancient Classic Formulas (First Batch)" published by the National Administration of Traditional Chinese Medicine, used for respiratory system medications. Its indicated functions are: to diffuse the lungs and relieve the exterior, to eliminate phlegm and stop cough. It is used for lung cold pathogens and cough.
Chongqing Taiji Industry to Buy Two Local Peers
Chongqing Taiji Industry(Group) Co.,Ltd's (SHSE:600129) Last Week's 4.1% Decline Must Have Disappointed Private Companies Who Have a Significant Stake
Chongqing Taiji Industry (600129.SH) plans to liquidate and deregister its subsidiary, Yangshengyuan Company.
Chongqing Taiji Industry (600129.SH) announced that the company will hold the tenth board meeting on December 16, 2024...
Chongqing Taiji Industry (600129.SH): plans to acquire 100% equity of its subsidiary and increase its capital.
Glory Exchange reported on December 17 that Chongqing Taiji Industry (600129.SH) announced that Tongqunge Pharmaceutical Factory, one of the pharmaceutical manufacturing enterprises under the company, intends to focus further on Operation and streamline the equity structure and management relations. The company plans to acquire 90.33% and 9.67% of the equity held by Chongqing Tongqunge Co., Ltd. (hereinafter referred to as Tongqunge shares) and Chongqing Tongqunge Chain Pharmacy Limited Liability Company (hereinafter referred to as Tongqunge Pharmacy) for a cash sum of 133.0657 million yuan and 14.2449 million yuan, respectively. After the acquisition is completed, the company will increase the cash capital of Tongqunge Pharmaceutical Factory by 32,000.
Sinolink: The end of year centralized purchasing expectations are gradually being cleared, and the pharmaceutical sector行情 is expected to gradually start.
The pharmaceutical Sector is currently in a process of a triple reversal in performance, policies, and funding, with full confidence in the recovery of revenue profit growth and market resurgence of listed companies in the Sector by 2025.
Chongqing Taiji Industry(Group) Co.,Ltd (SHSE:600129) Looks Inexpensive But Perhaps Not Attractive Enough
